MING SpareBank 1 SMN
SpareBank 1 SMN, together with its subsidiaries, provides various banking, accounting, and real estate products and services to private individuals and companies in Norway and internationally. The company offers deposits, savings and investment products, financing and real estate brokerage services, vehicle financing and leasing services, insurance products, credit and debit cards, loans, structured products, and stock trading and international payment services. It also provides bank guarantee, such as payment, lien, rent, loan, contract, other guarantees; documentary collection; foreign currency accounts; letters of credit; forward contracts; capital market and accounting services; and mobile, online, and other banking services. The company distributes its products through physical branches and digital channels, as well as a customer service center. SpareBank 1 SMN was founded in 1823 and is headquartered in Trondheim, Norway.…
Industry Peers
Banks - RegionalKey Statistics
About SpareBank 1 SMN (OSL: MING)
›
SpareBank 1 SMN (OSL: MING) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Banks - Regional industry, part of the Financial Services sector, and reports about 1,616 employees.
The shares were at 221.50 NOK on 20 November 2026, up 27.2% over 52 weeks. Its 52-week range is 181.72 NOK to 225.15 NOK: the price is 1.6% below the high and 21.9% above the low.
At a market capitalisation of 31.94B NOK, it trades at 12.6 times trailing earnings and 11.1 times forward earnings. The median trailing P/E of its 20 largest Banks - Regional peers is 10.3, a premium of 22% for MING. It pays a dividend yielding 6.07% (it pays out 77% of its earnings), against a median of 4.16% among the dividend payers in that peer group.
SpareBank 1 SMN reports return on equity of 13.7%, an operating margin of 58.4% and revenue down 8.1% year over year.
Its debt exceeds its cash by 44.57B NOK, a debt-to-equity ratio of 1.54. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 237.40 NOK is 7.2% above the current price. The next earnings report is expected on 11 February 2027.